The Patent Finder

Terms ending in 2038

Genmab A/S

Every in-force patent on Genmab A/S's record whose computed term ends in 2038, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresConfidence
US 12,595,316Bispecific and Multispecific Antibodies and Method for Isolation of Such
In force
 · High confidence
Genmab A/SIn forceHigh confidence
US 11,091,557Methods of Producing Multispecific Antibodies Against CD40 and CD137
In force
 · High confidence
BioNTech SEIn forceHigh confidence
US 11,034,772Bispecific ANTI-CD37 Antibodies, Monoclonal ANTI-CD37 Antibodies and Methods of Use Thereof
In force
 · High confidence
Genmab A/SIn forceHigh confidence
US 11,396,553Bispecific ANTI-CD37 Antibodies, Monoclonal ANTI-CD37 Antibodies and Methods of Use Thereof
In force
 · Low confidence
Genmab A/SIn forceLow confidence
US 11,512,137Bispecific ANTI-CD37 Antibodies, Monoclonal ANTI-CD37 Antibodies and Methods of Use Thereof
In force
 · High confidence
Genmab A/SIn forceHigh confidence
US 12,577,316Methods of Use of ANTI-CD37 Antibodies, Monoclonal ANTI-CD37 Antibodies
In force
 · High confidence
Genmab A/SIn forceHigh confidence
US 10,894,833Agents, Uses and Methods for Treatment
In force
 · High confidence
H. Lundbeck A/SIn forceHigh confidence
US 10,968,280Binding Agents Binding to PD-L1 and CD137 and Use Thereof
In force
 · High confidence
Genmab A/SIn forceHigh confidence
US 11,459,395Binding Agents Binding to PD-L1 and CD137 and Use Thereof
In force
 · High confidence
Genmab A/SIn forceHigh confidence
US 12,673,994Humanized or Chimeric CD3 Antibodies
In force
 · High confidence
Genmab A/SIn forceHigh confidence
10 of 10 patents shown. Soonest term end first, then patent number.
8 of these are in force and held by Genmab A/S.
Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited